Matthew Greenwood

Battery cost modeling: A review and directions for future research

F. Duffner, Marc Wentker, Matthew Greenwood, 2020 .

Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.

Matthew Greenwood, Martin Wilhelm, B. Coiffier, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.